Seeking Alpha

Intercept rallies ahead of conference, BofA defends lofty target

  • Investors will be watching Intercept Pharmaceuticals (ICPT) closely today after a wild ride during the last four trading sessions.
  • The company is set to present at the JPMorgan Healthcare Conference at 10:30 ET. Here's TheStreet's Adam Feuerstein: "[It's] going to be an adventure."
  • Meanwhile, BofA's Rachel McMinn (who caused a stir by putting an $872 price target on the shares last week) is out in defense of the stock, which has fallen over the past two days.
  • Ultimately, McMinn thinks investors need to be patient, given OCA's potential.
  • ICPT +7% premarket
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: